A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Prurigo Nodularis (PN)

NCT05764161 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

190

Enrollment

INDUSTRY

Sponsor class

Conditions

Prurigo Nodularis

Interventions

DRUG: Ruxolitinib Cream
DRUG: Vehicle Cream

Sponsor

Incyte Corporation